Autologous Adipose-derived Mesenchymal Stem Cells Therapy(CellinCells)
- Generic Name
- Autologous Adipose-derived Mesenchymal Stem Cells Therapy(CellinCells)
Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- CellinCells
- Target Recruit Count
- 3
- Registration Number
- NCT06210919
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath